Intervention Review

Sublingual immunotherapy for allergic rhinitis

  1. Suzana Radulovic1,*,
  2. Moises A Calderon2,
  3. Duncan Wilson3,
  4. Stephen Durham2

Editorial Group: Cochrane ENT Group

Published Online: 8 DEC 2010

Assessed as up-to-date: 13 AUG 2009

DOI: 10.1002/14651858.CD002893.pub2

How to Cite

Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD002893. DOI: 10.1002/14651858.CD002893.pub2.

Author Information

  1. 1

    Paediatric Allergy Research Department, King's College, LEAP Study Team, London, UK

  2. 2

    Royal Brompton Hospital, Department of Allergy and Respiratory Medicine, London, UK

  3. 3

    University Hospitals Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK

*Suzana Radulovic, LEAP Study Team, Paediatric Allergy Research Department, King's College, St. Thomas' Hospital, Lambeth Palace Road, London, SE1 7EH, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 DEC 2010


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.